Atherosclerosis

Papers
(The H4-Index of Atherosclerosis is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Latest European Atherosclerosis Society statement reaffirms commitment to the UN Sustainable Development Goals 2030 Agenda116
High incidence of heart failure in elderly patients with diabetes admitted in internal medicine department104
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells102
The emerging landscape of peptide-based inhibitors of PCSK985
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A83
The length of telomeres as an original biomarker of the risk of development of cardiovascular diseases and their complications82
CCL3/CCR5 and CX3CL1/CX3CR1 chemokine interactions are involved in T-cell accumulation in human atherosclerotic plaques81
Genetic analysis in Russian patients with familial hypercholesterolemia79
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease75
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack67
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes66
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study65
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk62
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients60
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways60
Lipid profile assessment as a factor of diabetic nephropathy progression59
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?58
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium57
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease56
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand55
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation55
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression52
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice52
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”51
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease50
Genome-wide association study on HDL-mediated cholesterol efflux capacity50
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?50
Illuminating the full spectrum of APOE variation50
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS48
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY47
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL46
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]44
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN44
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES43
Bivariate relation of vascular health and blood pressure progression during childhood43
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON43
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES42
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY42
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON39
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus39
0.057176828384399